147 related articles for article (PubMed ID: 34579909)
21. Hyaluronic acid thiol modified injectable hydrogel: Synthesis, characterization, drug release, cellular drug uptake and anticancer activity.
Xu K; Yao H; Fan D; Zhou L; Wei S
Carbohydr Polym; 2021 Feb; 254():117286. PubMed ID: 33357859
[TBL] [Abstract][Full Text] [Related]
22. Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance.
Wang L; Jia E
Drug Deliv; 2016 Jun; 23(5):1810-7. PubMed ID: 26530693
[TBL] [Abstract][Full Text] [Related]
23. Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity.
Lin Z; Gao W; Hu H; Ma K; He B; Dai W; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2014 Jan; 174():161-70. PubMed ID: 24512789
[TBL] [Abstract][Full Text] [Related]
24. Enhanced therapeutic effect of paclitaxel with a natural polysaccharide carrier for local injection in breast cancer.
Jang H; Zhi K; Wang J; Zhao H; Li B; Yang X
Int J Biol Macromol; 2020 Apr; 148():163-172. PubMed ID: 31935404
[TBL] [Abstract][Full Text] [Related]
25. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.
Lv Y; Xu C; Zhao X; Lin C; Yang X; Xin X; Zhang L; Qin C; Han X; Yang L; He W; Yin L
ACS Nano; 2018 Feb; 12(2):1519-1536. PubMed ID: 29350904
[TBL] [Abstract][Full Text] [Related]
26. Psoralen-loaded polymeric lipid nanoparticles combined with paclitaxel for the treatment of triple-negative breast cancer.
Liu F; Li L; Lan M; Zou T; Kong Z; Cai T; Wu X; Cai Y
Nanomedicine (Lond); 2021 Nov; 16(27):2411-2430. PubMed ID: 34749510
[No Abstract] [Full Text] [Related]
27. Deoxycholic acid modified-carboxymethyl curdlan conjugate as a novel carrier of epirubicin: in vitro and in vivo studies.
Gao F; Li L; Zhang H; Yang W; Chen H; Zhou J; Zhou Z; Wang Y; Cai Y; Li X; Liu L; Zhang Q
Int J Pharm; 2010 Jun; 392(1-2):254-60. PubMed ID: 20347028
[TBL] [Abstract][Full Text] [Related]
28. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
[TBL] [Abstract][Full Text] [Related]
29. Photothermal hyaluronic acid composite hydrogel targeting cancer stem cells for inhibiting recurrence and metastasis of breast cancer.
Wang T; Yu Y; Wang B; Jiang T; Meng X; Zhao X
Int J Biol Macromol; 2023 Dec; 252():126358. PubMed ID: 37598824
[TBL] [Abstract][Full Text] [Related]
30. Supramolecular hydrogel based on high-solid-content mPECT nanoparticles and cyclodextrins for local and sustained drug delivery.
Yin L; Xu S; Feng Z; Deng H; Zhang J; Gao H; Deng L; Tang H; Dong A
Biomater Sci; 2017 Mar; 5(4):698-706. PubMed ID: 28184404
[TBL] [Abstract][Full Text] [Related]
31. "Off/on" fluorescence imaging-guided cancer diagnosis and multi-modal therapy.
Wang C; Dong Y; Shi X; Guo J; Zhang J; Deng L; Lin Z; Huang P; Shi Y; Wang W; Dong A
Biomater Sci; 2020 Mar; 8(5):1442-1454. PubMed ID: 31960834
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral delivery of paclitaxel using a thermosensitive hydrogel in human tumor xenografts.
Kim JH; Lee JH; Kim KS; Na K; Song SC; Lee J; Kuh HJ
Arch Pharm Res; 2013 Jan; 36(1):94-101. PubMed ID: 23371803
[TBL] [Abstract][Full Text] [Related]
33. Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin.
Li L; Gao FP; Tang HB; Bai YG; Li RF; Li XM; Liu LR; Wang YS; Zhang QQ
Nanotechnology; 2010 Jul; 21(26):265601. PubMed ID: 20522924
[TBL] [Abstract][Full Text] [Related]
34. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
Yu D; Li W; Zhang Y; Zhang B
Biomed Pharmacother; 2016 Oct; 83():1428-1435. PubMed ID: 27592131
[TBL] [Abstract][Full Text] [Related]
35. Injectable gel self-assembled by paclitaxel itself for in situ inhibition of tumor growth.
Zhang K; Zhou L; Chen F; Chen Y; Luo X
J Control Release; 2019 Dec; 315():197-205. PubMed ID: 31669210
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel-based supramolecular hydrogel loaded with mifepristone for the inhibition of breast cancer metastasis.
Zhao CC; Zhang CG; Sun X; Guo Q; Liu J; Liu Y; Hao YN; Feng G; Yang L; Liu H; Liu J
Cancer Sci; 2022 Feb; 113(2):733-743. PubMed ID: 34859546
[TBL] [Abstract][Full Text] [Related]
37. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
[TBL] [Abstract][Full Text] [Related]
38. An injectable thermosensitive hydrogel self-supported by nanoparticles of PEGylated amino-modified PCL for enhanced local tumor chemotherapy.
Guo J; Feng Z; Liu X; Wang C; Huang P; Zhang J; Deng L; Wang W; Dong A
Soft Matter; 2020 Jun; 16(24):5750-5758. PubMed ID: 32529197
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy.
Zou J; Su S; Chen Z; Liang F; Zeng Y; Cen W; Zhang X; Xia Y; Huang D
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3456-3464. PubMed ID: 31469318
[TBL] [Abstract][Full Text] [Related]
40. A reconstituted "two into one" thermosensitive hydrogel system assembled by drug-loaded amphiphilic copolymer nanoparticles for the local delivery of paclitaxel.
Wang W; Deng L; Xu S; Zhao X; Lv N; Zhang G; Gu N; Hu R; Zhang J; Liu J; Dong A
J Mater Chem B; 2013 Jan; 1(4):552-563. PubMed ID: 32260827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
